A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

NCT07673887 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma

Interventions

DRUG: ASP2138
DRUG: Pembrolizumab
DRUG: Oxaliplatin
DRUG: Capecitabine
DRUG: Folinic acid
DRUG: 5-FU
DRUG: Placebo for ASP2138
DRUG: Placebo for Pembrolizumab

Sponsor

Astellas Pharma Global Development, Inc.